NCT00147875View on ClinicalTrials.gov

Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

July 31, 2007

Conditions

Hodgkin's Disease

Interventions

DRUG

Prednisone

DRUG

Vinblastine

DRUG

Doxorubicin (Adriamycin)

DRUG

Gemcitabine

Trial Locations (1)

50924

University of Cologne, Cologne

All Listed Sponsors

collaborator

German Hodgkin's Lymphoma Study Group

OTHER

collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Cologne

OTHER

NCT00147875 - Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter